We are live on
!
Find out more
SCCM
Schafer Cullen Capital Management Portfolio holdings
AUM
$491M
1-Year Est. Return
41.48%
This Fund
S&P 500
This Quarter
Est. Return
+4.59%
1 Year Est. Return
+41.48%
3 Year Est. Return
+28.44%
5 Year Est. Return
+53.22%
10 Year Est. Return
–
AUM
$7.79B
AUM Growth
+$407M
(+5.5%)
Cap. Flow
+$58.2M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
21.89%
Holding
313
New
22
Increased
100
Reduced
116
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$38.3M |
| 2 |
ASE Group
ASX
|
+$36.9M |
| 3 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$25.4M |
| 4 |
Healthpeak Properties
DOC
|
+$20.6M |
| 5 |
AstraZeneca
AZN
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$89.4M |
| 2 |
BAY
BAYER AG SPONS ADR
BAY
|
+$14M |
| 3 |
BCE
BCE
|
+$13M |
| 4 |
SJR
Shaw Communications Inc.
SJR
|
+$12.6M |
| 5 |
DT
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 16.79% |
| 2 | Financials | 15.01% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Staples | 11.23% |
| 5 | Industrials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
1
DELISTED
Unilever NV New York Registry Shares
UN
| $223M | 2.86% |
4,478,873
+12,313
| +0.3% | +$552K |
|
2
Novartis
NVS
$292B
| $189M | 2.43% |
2,842,802
+236,617
| +9% | +$15.8M |
|
3
JPMorgan Chase
JPM
$951B
| $172M | 2.21% |
1,957,849
-68,894
| -3% | -$6.08M |
|
|
RDS.B
4
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $169M | 2.18% |
3,033,479
+448,318
| +17% | +$25.4M |
|
5
Cisco
CSCO
$433B
| $164M | 2.11% |
4,853,978
-32,614
| -0.7% | -$1.06M |
|
6
Johnson & Johnson
JNJ
$646B
| $161M | 2.07% |
1,293,753
+2,827
| +0.2% | +$338K |
|
7
HSBC
HSBC
$355B
| $159M | 2.04% |
4,298,612
+158,888
| +4% | +$5.97M |
|
|
8
BCE
BCE
$21.9B
| $157M | 2.02% |
3,550,660
-296,138
| -8% | -$13M |
|
9
Chubb
CB
$131B
| $155M | 1.99% |
1,139,887
-7,380
| -0.6% | -$993K |
|
10
Altria Group
MO
$115B
| $155M | 1.99% |
2,166,203
-38,112
| -2% | -$2.76M |
|
11
AT&T
T
$178B
| $151M | 1.94% |
4,824,330
-15
| -0% | -$472 |
|
12
Microsoft
MSFT
$3.81T
| $151M | 1.94% |
2,291,509
-19,679
| -0.9% | -$1.26M |
|
13
Welltower
WELL
$172B
| $151M | 1.94% |
2,130,873
+18,282
| +0.9% | +$1.23M |
|
14
Diageo
DEO
$51.7B
| $145M | 1.87% |
1,256,267
+11,194
| +0.9% | +$1.26M |
|
15
Merck
MRK
$366B
| $142M | 1.83% |
2,350,292
-42,799
| -2% | -$2.6M |
|
|
DD
16
DELISTED
Du Pont De Nemours E I
DD
| $142M | 1.83% |
1,772,846
-23,503
| -1% | -$1.83M |
|
17
Philip Morris
PM
$299B
| $142M | 1.82% |
1,256,057
-71,401
| -5% | -$7.37M |
|
18
GE Aerospace
GE
$355B
| $139M | 1.79% |
975,231
+15,033
| +2% | +$2.18M |
|
19
Chevron
CVX
$396B
| $138M | 1.77% |
1,284,753
+21,982
| +2% | +$2.47M |
|
20
Boeing
BA
$166B
| $136M | 1.74% |
767,130
-59,233
| -7% | -$10.1M |
|
21
Wells Fargo
WFC
$262B
| $135M | 1.73% |
2,423,140
+34,529
| +1% | +$1.96M |
|
|
22
AstraZeneca
AZN
$252B
| $131M | 1.68% |
2,101,131
+277,426
| +15% | +$16.1M |
|
23
3M
MMM
$89.9B
| $129M | 1.66% |
807,874
-33,337
| -4% | -$5.11M |
|
24
NextEra Energy
NEE
$171B
| $127M | 1.63% |
3,947,400
-98,300
| -2% | -$3.09M |
|
25
Travelers Companies
TRV
$77.2B
| $126M | 1.61% |
1,041,652
+68,383
| +7% | +$8.22M |
|
Similar funds
CNC
SRAM
PA
FBP
SGMP
RG
LFA
RHFI
Schafer Cullen Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Schafer Cullen Capital Management held 313 positions worth $7.79B, up 5.5% from $7.38B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Schafer Cullen Capital Management's Q1 2017 filing shows 22 new, 100 increased, 116 reduced and 34 closed positions. Its largest new stake was Morgan Stanley: 111,425 shares worth $4.77M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $89.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
- Schafer Cullen Capital Management's largest Q1 2017 buy was Morgan Stanley: 111,425 shares worth $4.77M.
- Schafer Cullen Capital Management added most to SIEMENS AKTIENGESELLSCHAFT ADS in Q1 2017, an estimated $38.3M increase.
- Schafer Cullen Capital Management's biggest Q1 2017 reduction was BAYER AG SPONS ADR, cutting an estimated $14M.
- Schafer Cullen Capital Management fully exited iShares MSCI ACWI ex US ETF in Q1 2017, selling an estimated $89.4M.
- Schafer Cullen Capital Management's ten largest holdings make up 22% of its $7.79B portfolio in Q1 2017.
- Schafer Cullen Capital Management opened 22 new positions and closed 34 in Q1 2017.
- Schafer Cullen Capital Management's portfolio value rose 5.5% quarter-over-quarter to $7.79B.
Based on Schafer Cullen Capital Management's 13F filing for Q1 2017, filed 11 May 2017.